COMP <GO>
CVX vs COP // 10Y YIELD & FRED MACRO BETA
Chevron Corporation (NYSE) VS. ConocoPhillips (NYSE) • 15-METRIC TALLY: CVX 3
— COP 11
▲ 10Y YIELD & FRED MACRO BETA LEADER: COP
LAST: $227.77 (-3.29%) • MKT CAP: $465.33B
macro-sensitivity
1.07
LAST: $146.84 (-4.67%) • MKT CAP: $185.04B
macro-sensitivity
1.16
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVX VS. COP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVX | COP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.30% | 56.90% | -15.60 | COP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.80% | 9.40% | -3.60 | COP | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.5x | 16.9x | +4.60 | COP | /valuation <GO> |
| Free Cash Flow Yield | 5.61% | 9.69% | -4.08 | COP | /fcf-yield <GO> |
| Operating Margin | 8.10% | 18.80% | -10.70 | COP | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 15.40% | -8.70 | COP | /net-margins <GO> |
| Revenue Growth (YoY) | -4.60% | 4.90% | -9.50 | COP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.79% | 2.22% | +0.57 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.71 | 3.40 | +0.31 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | COP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.8 | 69.1 | -0.30 | COP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.07 | 1.16 | -0.09 | COP | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.6x | 21.0x | +13.60 | COP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $465.33B | $185.04B | $280.29B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVX REV | COP REV | CVX GROSS % | COP GROSS % | CVX FCF | COP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $184.43B | $51.82B | 41.3% | 56.9% | $25.64B | $17.46B |
| FY 2024 | $193.41B | $49.42B | 38.4% | 59.5% | $22.79B | $17.90B |
| FY 2023 | $196.91B | $48.52B | — | — | $26.75B | $17.78B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVX // BETA 1.07
COP // BETA 1.16